Journal of Natural Products · 2010 · 58 citations · 16 references
Life SciencesMedicinal ChemistryMicrobiologyAntimicrobial ResistanceDrug DiscoveryStructure-activity RelationshipsAntibiotic ResistanceAntibiotic Resistance MechanismsEfflux-mediated ResistanceMultidrug ResistanceResistance In Gram-negative BacteriaResistance In Gram-positive BacteriaAntibiotic DiscoveryAntibiotic Efflux ResistanceAntibiotic Resistance ScreeningMinimum Inhibitory Concentration DeterminationMultidrug-resistant Gram-negative BacteriaNovel Antibacterial Drug DiscoveryResistance Mechanisms In Gram-negative BacteriaResistance Mechanisms In Staphylococci
Two new norlignans, hyperiones A (1) and B (2), three new acylphloroglucinols, aspidinol C (3) and hyperaspidinols A (5) and B (6), the known compound aspidinol D (4), and the symmetrical dimeric xanthone hyperidixanthone (7) were isolated from Hypericum chinense. Their structures were established by spectroscopic analysis. In an antibacterial assay using a panel of multidrug-resistant (MDR) strains, compounds 3 and 4 exhibited promising activity against the NorA efflux protein overexpressing MDR Staphylococcus aureus strain SA-1199B with a minimum inhibitory concentration (MIC) of 2 μg/mL (8.4 μM) and 4 μg/mL (16.8 μM), respectively. The positive control antibiotic norfloxacin showed activity at MIC 32 μg/mL (100 μM).
16
Simon Gibbons, Edet E. Udo · Phytotherapy Research · 2000 · 206 citations
J.I. Ross, Angela Farrell, E. Anne Eady et al. · Journal of Antimicrobial Chemotherapy · 1989 · 120 citations · Full text